Search company, investor...

Graftys

graftys.com

Founded Year

2005

Stage

Unattributed VC - II | Alive

Total Raised

$11.93M

Last Raised

$2M | 8 mos ago

About Graftys

Graftys is an early-stage company focused on advanced bone biologics.

Headquarters Location

Eiffel Park – Bâtiment D 415, rue Claude Nicolas Ledoux

Aix-en-Provence, 13854,

France

+33 (4) 42 60 30 00

Missing: Graftys's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Graftys's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Graftys

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Graftys is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Graftys Patents

Graftys has filed 11 patents.

The 3 most popular patent topics include:

  • Biomaterials
  • Orthopedic surgical procedures
  • Calcium minerals
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/6/2017

7/26/2022

Biomaterials, Sheep breeds, Orthopedic surgical procedures, Phosphates, Polysaccharides

Grant

Application Date

4/6/2017

Grant Date

7/26/2022

Title

Related Topics

Biomaterials, Sheep breeds, Orthopedic surgical procedures, Phosphates, Polysaccharides

Status

Grant

Latest Graftys News

“GRAFTYS SA (Belgium) announces acquisition of French company Biologics4Life along with new equity investment of $3M (2.6M€)”

Nov 29, 2021

%PDF-1.4 %âãÏÓ11 0 obj > endobjxref11 570000000016 00000 n0000001730 00000 n0000001791 00000 n0000001970 00000 n0000002226 00000 n0000002594 00000 n0000002909 00000 n0000003236 00000 n0000003559 00000 n0000003707 00000 n0000004136 00000 n0000004421 00000 n0000004574 00000 n0000004609 00000 n0000008918 00000 n0000009148 00000 n0000009783 00000 n0000015094 00000 n0000015324 00000 n0000016037 00000 n0000018793 00000 n0000019028 00000 n0000019527 00000 n0000020573 00000 n0000021532 00000 n0000022445 00000 n0000023431 00000 n0000023579 00000 n0000024464 00000 n0000025463 00000 n0000026366 00000 n0000027117 00000 n0000029824 00000 n0000033388 00000 n0000033631 00000 n0000034164 00000 n0000037889 00000 n0000038127 00000 n0000038687 00000 n0000042151 00000 n0000042394 00000 n0000042942 00000 n0000043291 00000 n0000043521 00000 n0000043814 00000 n0000050642 00000 n0000050861 00000 n0000051154 00000 n0000051512 00000 n0000051747 00000 n0000052040 00000 n0000070174 00000 n0000099142 00000 n0000182594 00000 n0000185627 00000 n0000190474 00000 n0000001436 00000 ntrailer]/Prev 208992>>startxref0%%EOF67 0 obj

Graftys Frequently Asked Questions (FAQ)

  • When was Graftys founded?

    Graftys was founded in 2005.

  • Where is Graftys's headquarters?

    Graftys's headquarters is located at Eiffel Park – Bâtiment D, Aix-en-Provence.

  • What is Graftys's latest funding round?

    Graftys's latest funding round is Unattributed VC - II.

  • How much did Graftys raise?

    Graftys raised a total of $11.93M.

  • Who are the investors of Graftys?

    Investors of Graftys include Noshaq, Go Capital, Ouest Ventures, TheClubDeal, Smalt Capital and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.